SYRE
SYRE
NASDAQ · Biotechnology

Spyre Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$96.64
-2.40 (-2.42%)
As of Nov 5, 8:45 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target -18.3% upside
Low Target $58.92
Average Target $78.92
High Target $128.60
Current Price $96.64
Current
$96.64
Target
$78.92
$58.92 $78.92 avg $128.60
Scenario Analysis
Bear Case
$58.92
-39.0%
Low target
Base Case
$78.92
-18.3%
Avg target
Bull Case
$128.60
+33.1%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$110.18
-12.3% from high
52-Week Low
$21.15
+357.0% from low
50-Day SMA
$89.52
+8.0% vs SMA
200-Day SMA
$74.19
+30.3% vs SMA
RSI (14)
78.3
Overbought
Target vs 52W High
$78.92
-28.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -10.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +116.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -38.1%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -60.7%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -35.8%